Nathaniel Weygant

10PUBLICATIONS
10CO-AUTHORS
Cancer cell biologyMolecular targetsAutoimmunityHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 12, 2026
Testican-1 activates Wnt/β-Catenin signaling to drive colorectal cancer progression.

|Nov 11, 2022
Bufalin Inhibits Tumorigenesis, Stemness, and Epithelial-Mesenchymal Transition in Colorectal Cancer through a C-Kit/Slug Signaling Axis.

Ling Ding, Yuning Yang, Qin Lu

|Nov 27, 2021
Inhibition of DCLK1 with DCLK1-IN-1 Suppresses Renal Cell Carcinoma Invasion and Stemness and Promotes Cytotoxic T-Cell-Mediated Anti-Tumor Immunity.

Ling Ding, Yuning Yang, Yang Ge

|Oct 06, 2021
DCLK1-Short Splice Variant Promotes Esophageal Squamous Cell Carcinoma Progression via the MAPK/ERK/MMP2 Pathway.

Yang Ge, Xiaona Fan, Xuying Huang

|Dec 22, 2020
Tuft and Cancer Stem Cell Marker DCLK1: A New Target to Enhance Anti-Tumor Immunity in the Tumor Microenvironment.

Zhiyun Cao, Nathaniel Weygant, Parthasarathy Chandrakesan

|Nov 12, 2020
Tuft cells: an emerging therapeutic target for pancreatitis and pancreatic cancer?

Yuning Yang, Ling Ding, Zhiyun Cao

Pageof 2

Frequent Collaborators

4 joint publications

Yang Ge

2 joint publications

Parthasarathy Chandrakesan

2 joint publications

Dongfeng Qu

2 joint publications

Jian Liu